Pricing Log in Create free account

Iovance Biotherapeutics, Inc. (IOVA) vs Disc Medicine, Inc. (IRON)

Iovance Biotherapeutics, Inc. and Disc Medicine, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. and Disc Medicine, Inc. are of similar size ($3.5B and $3.5B). Disc Medicine, Inc. has the higher net margin (0.00% vs −58.2%) and the higher return on invested capital (0.00% vs −17.7%). Across the 13 metrics below, Iovance Biotherapeutics, Inc. leads on 8 and Disc Medicine, Inc. on 5.

Valuation

Metric IOVA IRON Biotechnology median
P/E n/m n/m 10.26
P/S 9.29 n/m 9.18
P/B 4.33 4.74 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 8.51 n/m 8.98
Earnings yield (6.78%) (8.33%) (34.89%)
Free cash flow yield (6.14%) (6.50%) (24.52%)

Profitability

Metric IOVA IRON Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin (60.79%) 0.00% 0.00%
Net margin (58.19%) 0.00% 0.00%
Free cash flow margin (57.01%) 0.00% 0.00%
Return on equity (29.11%) (39.08%) (50.12%)
Return on assets (23.26%) (35.12%) (45.60%)
Return on invested capital (17.72%) 0.00% 0.00%

Growth

Metric IOVA IRON Biotechnology median
Revenue growth (TTM) 51.34% — 6.26%
EPS growth (last fiscal year) 14.84% (51.77%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOVA IRON Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 5.20 24.14 4.89
Net debt to EBITDA 0.82 3.12 1.01

Dividend

Metric IOVA IRON Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IOVA IRON Biotechnology median
Market cap 3.51b 3.48b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack